Volume 6.48 | Dec 19

Immune Regulation News 6.48 December 19, 2014
Immune Regulation News
     In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  IRN on Twitter
Multiple Allergic Reactions Traced to Single Protein
Scientists have identified a single protein as the root of painful and dangerous allergic reactions to a range of medications and other substances. [Press release from Johns Hopkins Medicine discussing online prepublication in Nature] Press Release | Abstract
Hassle-Free PBMC Isolation in Just 15 Minutes
PUBLICATIONS (Ranked by impact factor of the journal)
MAVS, cGAS, and Endogenous Retroviruses in T-Independent B Cell Responses
Investigators report that immunization with T cell-independent type 2 antigens causes up-regulation of endogenous retrovirus RNAs in antigen-specific mouse B cells. [Science] Abstract | Press Release

Detection of Self-Reactive CD8+ T Cells with an Anergic Phenotype in Healthy Individuals
The authors show that regulatory T cells can render self-reactive human CD8+ T cells anergic in vitro, likely by controlling the costimulatory function of antigen-presenting cells. They detected in healthy individuals anergic T cells reactive with a skin antigen targeted in the autoimmune disease vitiligo. [Science] Abstract

Myeloid-Derived Suppressor Activity Is Mediated by Monocytic Lineages Maintained by Continuous Inhibition of Extrinsic and Intrinsic Death Pathways
Using genetic manipulation of cell death pathways, scientists found the monocytic suppressor-cell subset, but not the granulocytic subset, requires continuous c-FLIP expression to prevent caspase-8-dependent, RIPK3-independent cell death. [Immunity] Abstract | Graphical Abstract | Press Release

The Coinhibitory Receptor CTLA-4 Controls B Cell Responses by Modulating T Follicular Helper, T Follicular Regulatory, and T Regulatory Cells
Researchers show deletion of CTLA-4 in adult mice increased Tfh and Tfr cell numbers and augmented B cell responses. In the effector phase, loss of CTLA-4 on Tfh cells resulted in heightened B cell responses, whereas loss of CTLA-4 on Tfr cells resulted in defective suppression of antigen-specific antibody responses. [Immunity] Full Article | Graphical Abstract

Essential Role for Autophagy during Invariant NKT Cell Development
Scientists report that, in mice with a conditional deletion of the essential autophagy gene Atg7 in the T-cell compartment, thymic invariant natural killer T (iNKT) cell development—unlike conventional T-cell development—is blocked at an early stage and mature iNKT cells are absent in peripheral lymphoid organs. [Proc Natl Acad Sci USA] Abstract | Full Article

PTPN2 Controls Differentiation of CD4+ T Cells and Limits Intestinal Inflammation and Intestinal Dysbiosis
Loss of protein tyrosine phosphatase non-receptor type 2 (PTPN2) in the T-cell compartment causes enhanced induction of T helper (Th)1 and Th17 cells, but impaired induction of regulatory T cells in several mouse colitis models. This results in increased susceptibility to intestinal inflammation and intestinal dysbiosis which is comparable with that observed in Crohn’s disease patients. [Mucosal Immunol] Abstract

Alarmins MRP8 and MRP14 Induce Stress Tolerance in Phagocytes under Sterile Inflammatory Conditions
Scientists demonstrate that the endogenous alarmins MRP8 and MRP14 induce phagocyte hyporesponsiveness via chromatin modifications in a Toll-like receptor 4-dependent manner that results in enhanced survival to septic shock in mice. [Cell Rep] Full Article | Graphical Abstract

The Kinase Itk and the Adaptor TSAd Change the Specificity of the Kinase Lck in T Cells by Promoting the Phosphorylation of Tyr192
Researchers found that a conserved tyrosine phosphorylation site (Tyr192) within the Src homology 2 domain of Lck was required for proper T cell activation and formation of cell-cell conjugates between T cells and antigen-presenting cells. [Sci Signal] Abstract

HSP70 Mediates Degradation of the p65 Subunit of Nuclear Factor κB to Inhibit Inflammatory Signaling
Investigators found that the chaperone protein HSP70 (heat shock protein of 70 kD) was required for the PDLIM2-mediated degradation of p65 and suppression of nuclear factor κB signaling in lipopolysaccharide-treated dendritic cells. [Sci Signal] Abstract

Functional Expression Cloning Identifies COX-2 as a Suppressor of Antigen-Specific Cancer Immunity
Using functional expression cloning and T-cell receptor transgenic mice, scientists identified cyclooxygenase 2/prostaglandin-endoperoxide synthase 2 (COX-2) as resistance factor against the cytotoxicity induced by activated, antigen-specific T cells. [Cell Death Dis] Full Article

Leukotrienes Induce the Migration of Th17 Cells
Researchers show that Th17 cells express high levels of leukotriene B4 receptor 1 (LTB4R1) and cysteinyl leukotriene receptor 1 (CysLTR1). Th17 cells migrated under the guidance of leukotriene B4 and D4. The migration of Th17 cells was more efficient than that of Th1 and Th2 cells, and it was blocked by specific inhibitors of LTB4R1 or CysLTR1. [Immunol Cell Biol] Abstract

Subscribe to our sister publications:
Human Immunology News and Immunology of Infectious Disease News

New EasySep™ 15-Minute Mouse Cell Isolation Kits - Calculate Time Savings
The Immunology of Asthma
The authors discuss results from in-depth molecular studies of mouse models in light of the results from the first clinical trials targeting key cytokines in humans and describe the extraordinary heterogeneity of asthma. [Nat Immunol] Abstract

Antiviral B Cell and T Cell Immunity in the Lungs
Well-timed, appropriately placed and tightly regulated T cell and B cell responses are essential for protection from infection and limitation of symptoms, whereas poorly regulated inflammation contributes to tissue damage and disease. Recent advances in understanding adaptive immunity should facilitate vaccine development and reduce the global effect of respiratory viruses. [Nat Immunol] Abstract

Visit our reviews page to see a complete list of reviews in the immune regulation research field.
Kadmon Corporation Presents Preclinical Data on KD025 in Chronic Graft-versus-Host-Disease
Kadmon Corporation, LLC, announced the presentation of preclinical data showing that KD025, the company’s Phase II, orally bioavailable, potent and highly selective inhibitor of ROCK2 (Rho-associated coiled-coiled kinase 2), effectively reverses chronic graft-versus-host disease in murine models. [Press release from Kadmon Corporation, LLC, discussing research presented at the 56th Annual Meeting of the American Society of Hematology (ASH), San Francisco] Press Release

From our sponsor: Free Nature Reviews Immunology poster – Immune Response to HIV. Request a copy.
Compugen Enters Immuno-Oncology Research Collaboration with Johns Hopkins University
Compugen Ltd. announced the initiation of a multi-year research collaboration with Johns Hopkins University, School of Medicine. The collaboration will focus on further evaluation of selected novel B7/CD28-like immune checkpoint candidates discovered by Compugen for the potential treatment of cancer. [Compugen Ltd.] Press Release

ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine
ImmunoCellular Therapeutics, Ltd. announced that the US Patent and Trademark Office has issued a key patent covering ImmunoCellular’s product candidate ICT-107, a dendritic cell-based immunotherapeutic vaccine targeting six tumor antigens that are commonly expressed on glioblastoma. [ImmunoCellular Therapeutics, Ltd.] Press Release

Inovio Pharmaceuticals Initiates DNA Immunotherapy Trial for Breast, Lung and Pancreatic Cancers
Inovio Pharmaceuticals, Inc. announced it has initiated a Phase I trial of its hTERT DNA immunotherapy alone or in combination with Inovio’s IL-12 immune activator in adults with breast, lung, or pancreatic cancer at high risk of relapse after surgery and other cancer treatments. [Inovio Pharmaceuticals, Inc.] Press Release
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
NEW 4th International Conference on Immunochemotherapy
April 16-17, 2015
Philadelphia, United States

Visit our events page to see a complete list of events in the immune regulation community.
NEW Research Associate (Qu Biologics Inc.)

Postdoctoral Fellow – Tyrosine Phosphatase in Rheumatoid Arthritis (La Jolla Institute for Allergy & Immunology)

Postdoctoral Research Associate – Immunology (University of Edinburgh)

Postdoctoral Position – Immunology (Centre Léon Bérard)

Postdoctoral Position – Mucosal Immunology (Karolinska Institute)

Research Associate – B Cell Biology (King’s College London)

Researcher – Antitumor Immune Cell Response (ACAVI)

Product Manager Global Marketing – Autoimmunity (Thermo Fisher Scientific)

Scientist – Recombinant Molecules and Antibodies (STEMCELL Technologies Inc.)

Scientist – Pluripotent Stem Cell Media Development, High Throughput Screening (STEMCELL Technologies Inc.)

Scientist – Cell Culture Support Products (STEMCELL Technologies Inc.)

Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in Immune Regulation News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Immune Regulation News: Archives | Events | Contact Us